Dr. Rob Swaney is a pharmacist who is specialized in Oncology in Bellevue, Nebraska. Patients can reach him at 2500 Bellevue Medical Center Dr, Bellevue or contact him on 402-763-3494. Active license number of Dr. Rob Swaney is 11503 for Oncology in Nebraska. Dr. Rob Swaney is a licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Complete Profile:
Dr. Rob Swaney speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Dr. Rob Swaney
Specialization:
Oncology
Credentials:
PHARMD
Gender:
Male
Location:
2500 Bellevue Medical Center Dr, Bellevue, Nebraska, 68123-1591
Phone:
402-763-3494
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Dr. Rob Swaney are as mentioned below.
NPI Number:
1932779592
NPI Enumeration Date:
28 Jun, 2021
NPI Last Update On:
28 Jun, 2021
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Rob Swaney are as mentioned below.
Specialization
License Number
State
Status
Oncology
11503
Nebraska
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
18332 Jefferson St, Omaha, Nebraska
Zip:
68135-1758
Phone Number:
402-214-5083
Fax Number:
--
Patients can reach Dr. Rob Swaney at 2500 Bellevue Medical Center Dr, Bellevue, Nebraska or can call on phone at 402-763-3494.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.